The incidence of CVD after HCT was highest in patients with CHIP and hypertension or dyslipidemia (30% each), corresponding to nearly 7-fold and 4-fold increased risk of CVD, respectively, compared with those without CHIP and these modifiable risk factors. Here, STUB1 is linked to metabolic syndrome.